Bullish Moving Averages
0
Bearish Moving Averages
16
Back Stocks profile
Stock analysis tool for investors
Performance
Open Price
8.80Prev. Close
10.9600Volume
207000.00Value
1711890.00Fundamentals
Market Cap Cr
19.90
Price to Earnings
0.00
Price to Book Value
0.80
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM Cr
0.00
Net Profit TTM Cr
0.00
Cash From Operating Activity Cr
-20.98
Return on Equity %
3.74
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
08 May, 2024
88.4
Week
77.8
Month
63.3
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
8.41
PIVOT
First Resistance
8.61
Second Resistance
8.96
Third Resistance
9.16
First Support
8.06
Second Support
7.86
Third Support
7.51
Relative Strength Index
35.72
Money Flow Index
43.61
MACD
-0.45
MACD Signal
-0.46
Average True Range
0.67
Average Directional Index
10.04
Rate of Change (21)
-18.12
Rate of Change (125)
-42.29
Commodity Channel Index
-127.8
Williams %R
-86.9
BETA
1 Month
3.97
3 Month
1.84
1 Year
1.01
3 Year
PRICE CHANGE ANALYSIS
↓ -8.52%
1 Week
Low
High
8.2
9.26
↓ -17.87%
1 Month
Low
High
8
11.15
↓ -48.76%
3 Months
Low
High
8
17.38
↓ -42.17%
6 Months
Low
High
8
17.38
↓ -48.63%
1 Year
Low
High
8
29.35
06 May 2024
Dipna Pharmachem Ltd - 543594 - Board Meeting Outcome for Outcome Of Board Meeting Held On 6Th May, 2024
Outcome of Board Meeting held on 6th May, 2024
02 May 2024
Dipna Pharmachem Ltd - 543594 - Board Meeting Intimation for Re-Schedule Of Board Meeting Held Today I.E. 2Nd May, 2024
Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2024 ,inter alia, to consider and approve Pursuant to the second proviso to Regulation 30(6) of the SEBI (LODR) Regulations, 2015, we hereby inform you the Board of Directors of the Company meeting held today i.e. Thursday, 2nd May, 2024 which commenced at 2:00 P.M., and Concluded at 7:30 P.M., at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India, 380055, has decided to Re-schedule the meeting to be held on 6th May, 2024 for discuss and consider, inter-alia: ? The proposal of issue of Bonus equity shares to the existing equity shareholders of the Company. ? The proposal of sub-division of equity shares of the Company. ? The proposal of raising of funds by way of issue of Equity shares and/ or Warrants on preferential basis. Note that meeting is reschedule due to requirement of expert advice.
01 May 2024
Dipna Pharmachem Ltd - 543594 - Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Statement on Deviation or Variation of funds under Regulation 32 of SEBI (LODR) Regulations, 2015.
27 Apr 2024
Dipna Pharmachem Ltd - 543594 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended On 31St March, 2024
Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015.
26 Apr 2024
Dipna Pharmachem Ltd - 543594 - Submission Of Certificate Under Regulation 40(9) Read With Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended On 31St March, 2024
Submission of Certificate under Regulation 40(9) read with Regulation 40(10) of SEBI (LODR) Regulations, 2015 for the financial year ended on 31st March, 2024.
25 Apr 2024
Dipna Pharmachem Ltd - 543594 - Board Meeting Intimation for Intimation For Rescheduling Of Board Meeting From 26Th April, 2024 To 2Nd May, 2024
Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company which was supposed to be held on Friday, 26th April, 2024 at 2:00 P.M., is now rescheduled to Thursday, 2nd May, 2024 at 2:00 P.M. at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India, 380055, to discuss and consider, inter-alia: 1. The proposal of issue of Bonus equity shares to the existing equity shareholders of the Company. 2. The proposal of sub-division of equity shares of the Company. 3. The proposal of raising of funds by way of issue of Equity shares and/ or Warrants on preferential basis.
22 Apr 2024
Dipna Pharmachem Ltd - 543594 - Update on board meeting
Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/04/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015, we hereby inform you that in continuation to the intimation submitted on 8th April, 2023 vide Acknowledgement No.: 7079374 to the Exchange, in the meeting of the Board of Directors of the Company which will be held on Friday, 26th April, 2024 at 2:00 P.M., at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India, 380055, the agenda of raising of funds by way of issue of Equity shares and/ or Warrants on preferential basis shall also be placed for discussion and consideration. Further, this intimation is submitted to the reference of Board meeting held will be held on 26th April, 2024 and the link of the earlier announcement is https://www.bseindia.com/xmldata/ corpfiling/AttachHis/f00282ab-9375-4f0b-bd73 2463d3c5554b.pdf
18 Apr 2024
Dipna Pharmachem Ltd - 543594 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanjay Sevantilal Shah
18 Apr 2024
Dipna Pharmachem Ltd - 543594 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nishil Financial Advisors LLP
18 Apr 2024
Dipna Pharmachem Ltd - 543594 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanjay Shah
